Table 1.

Studies of renal cell cancer that include more than five patients

Ref.	Yr	n	5-yr survival	Median survival
Butturini et al[56]	1998	5	NR	24.5 mo
La Borgne et al[15]	2000	5	0%	35.5 mo
Kassabian et al[11]	2000	5	67%	Not reached
Ghavamian et al[59]	2000	11	81%	120 mo
Hioits et al[14]	2001	10	NR	4-8 yr
Faure et al[21]	2001	9	88%	Not reached
Law et al[22]	2003	14	75%	Not reached
Wente et al[27]	2005	15	NR	Not reached
Kohler et al[61]	2006	5	100%	Not reached
Crippa et al[10]	2006	5	80%	Not reached
Eidit et al[57]	2007	7	88%	Not reached
Varker et al[60]	2007	5	NR	Not reached
Bahra et al[55]	2007	9	100%	Not reached
Zerbi et al[12]	2008	23	88%	Not reached
Reddy et al[54]	2008	21	45%	58 mo
Tanis et al[63]	2009	10	NR	Not reached
Masetti et al[35]	2010	6	NR	Not reached
Konstantinidis et al[62]	2010	20	61%	8.7 yr

NR: Data not reported. Survival data is from the time of resection of the pancreatic metastasis, not from diagnosis of the primary tumor.